2004
DOI: 10.1016/j.ygyno.2003.12.024
|View full text |Cite
|
Sign up to set email alerts
|

Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(16 citation statements)
references
References 33 publications
0
16
0
Order By: Relevance
“…The mechanism of HE4 overexpression in ovarian cancer is not clear. However, it has been demonstrated that the chromosomal region where HE4 is located is frequently amplified in ovarian cancer and breast cancer (Berry et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…The mechanism of HE4 overexpression in ovarian cancer is not clear. However, it has been demonstrated that the chromosomal region where HE4 is located is frequently amplified in ovarian cancer and breast cancer (Berry et al, 2004).…”
Section: Discussionmentioning
confidence: 99%
“…33 Similar studies have evaluated the use of the promoter for the WFDC family member SLPI for gene therapy in ovarian and cervical carcinomas. [34][35][36] In summary, our results characterize the distribution of HE4 in normal adult tissues and various malignancies.…”
Section: Discussionmentioning
confidence: 99%
“…We also found that HE4 translocated to the nuclei or nucleoli of SKOV3 and OVCAR8 wild type cells following stimulation with 17b-estradiol or sub-toxic concentrations of fulvestrant or tamoxifen. This suggested that HE4 signaling is responsive to estrogens and antiestrogens; indeed, genomic analysis of the HE4 promoter region identified several hormonal responsive elements including estrogen receptor (ER) and RAR-related orphan receptor A (RORA), which may play a role in HE4 upregulation in ovarian cancer 21 . Confocal fluorescence for ER-a also showed that ER-a internalized to the nucleus upon stimulation with estrogens and antiestrogens.…”
Section: Discussionmentioning
confidence: 99%